Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) in Patients With Advanced Cancer
Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the highest dose of Liposome Entrapped Paclitaxel
Easy to Use formulation (LEP-ETU) that can be safely administered by an intravenous infusion
to patients with advanced cancer.